A key role for the integrin alpha2beta1 in experimental and developmental angiogenesis.
The alpha2beta1 integrin receptor plays a key role in angiogenesis. Here we investigated the effects of small molecule inhibitors (SMIs) designed to disrupt integrin alpha2 I or beta1 I-like domain function on angiogenesis. In unchallenged endothelial cells, fibrillar collagen induced robust capillary morphogenesis. In contrast, tube formation was significantly reduced by SMI496, a beta1 I-like domain inhibitor and by function-blocking anti-alpha2beta1 but not -alpha1beta1 antibodies. Endothelial cells bound fluorescein-labeled collagen I fibrils, an interaction specifically inhibited by SMI496. Moreover, SMI496 caused cell retraction and cytoskeletal collapse of endothelial cells as well as delayed endothelial cell wound healing. SMI activities were examined in vivo by supplementing the growth medium of zebrafish embryos expressing green fluorescent protein under the control of the vascular endothelial growth factor receptor-2 promoter. SMI496, but not a control compound, interfered with angiogenesis in vivo by reversibly inhibiting sprouting from the axial vessels. We further characterized zebrafish alpha2 integrin and discovered that this integrin is highly conserved, especially the I domain. Notably, a similar vascular phenotype was induced by morpholino-mediated knockdown of the integrin alpha2 subunit. By live videomicroscopy, we confirmed that the vessels were largely nonfunctional in the absence of alpha2beta1 integrin. Collectively, our results provide strong biochemical and genetic evidence of a central role for alpha2beta1 integrin in experimental and developmental angiogenesis.
San Antonio
James D
JD
Department of Pathology, Anatomy and Cell Biology, 1020 Locust Street, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Zoeller
Jason J
JJ
Habursky
Kari
K
Turner
Kevin
K
Pimtong
Wittaya
W
Burrows
Michelle
M
Choi
Sungwook
S
Basra
Sandeep
S
Bennett
Joel S
JS
DeGrado
William F
WF
Iozzo
Renato V
RV
D000818:Animals; D030801:Animals, Genetically Modified; D019138:Antibodies, Blocking; D002448:Cell Adhesion / Q000502:physiology; D002465:Cell Movement / Q000502:physiology; D002478:Cells, Cultured; D003094:Collagen; D004151:Dipeptides / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000166:cytology / Q000502:physiology; D006801:Humans; D038982:Integrin alpha2beta1 / Q000037:antagonists & inhibitors / Q000502:physiology*; D018919:Neovascularization, Physiologic / Q000502:physiology*; D017434:Protein Structure, Tertiary; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000502:physiology; D015027:Zebrafish
D019138:Antibodies, Blocking; D004151:Dipeptides; D038982:Integrin alpha2beta1; C545492:SMI496; D003094:Collagen; D040301:Vascular Endothelial Growth Factor Receptor-2
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13612-7
9391074
PLoS Genet. 2007 May 25;3(5):e78
17530925
Microsc Res Tech. 2008 May;71(5):339-48
18300285
J Med Chem. 2007 Nov 1;50(22):5457-62
17915848
Cell. 2000 Mar 31;101(1):47-56
10778855
Matrix Biol. 2002 Nov;21(7):547-58
12475639
J Med Chem. 2007 May 31;50(11):2742-6
17447751
Development. 2003 Nov;130(21):5281-90
12954720
Trends Cell Biol. 2005 Jan;15(1):52-60
15653078
Exp Cell Res. 1996 Apr 10;224(1):39-51
8612690
Biochemistry. 2000 Aug 15;39(32):9859-67
10933804
Science. 2000 Aug 18;289(5482):1197-202
10947988
Cancer Cell. 2002 Apr;1(3):257-67
12086862
J Invest Dermatol. 2007 Feb;127(2):467-78
16977325
Proc Natl Acad Sci U S A. 2000 Nov 21;97(24):12965-9
11087852
J Mol Biol. 2004 Jan 23;335(4):1019-28
14698296
Curr Pharm Des. 2005;11(7):867-80
15777240
J Biol Chem. 2005 Nov 4;280(44):36873-82
16103112
Curr Opin Hematol. 2008 May;15(3):197-203
18391785
Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8
12516034
Bioorg Med Chem Lett. 2006 Jul 1;16(13):3380-2
16678410
Nature. 2007 Feb 15;445(7129):781-4
17259972
Am J Pathol. 2002 Jan;160(1):195-204
11786413
Proteome Sci. 2008 Feb 12;6:7
18269764
Nat Biotechnol. 2004 May;22(5):595-9
15097998
Curr Biol. 2001 Oct 2;11(19):1481-91
11591315
BMC Cell Biol. 2006 Jun 20;7:24
16787535
Am J Pathol. 2002 Jul;161(1):337-44
12107118
Development. 2002 Feb;129(4):973-82
11861480
Circ Res. 2005 Nov 25;97(11):1093-107
16306453
Biochem J. 2003 Nov 15;376(Pt 1):77-85
12871211
J Biol Chem. 2003 Aug 15;278(33):30516-24
12788934
Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):911-2
12740225
J Biol Chem. 2008 Jan 25;283(4):2335-43
18024432
Blood. 2008 Apr 1;111(7):3562-70
18198349
J Natl Cancer Inst. 2006 Nov 15;98(22):1634-46
17105986
FEBS J. 2007 Mar;274(6):1481-91
17489103
J Biol Chem. 2003 Feb 7;278(6):4238-49
12435733
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):719-24
19141632
Nat Rev Mol Cell Biol. 2005 Aug;6(8):646-56
16064139
Dev Biol. 2001 Feb 15;230(2):278-301
11161578
J Cell Biol. 2008 Apr 21;181(2):381-94
18426981
Nat Genet. 2000 Oct;26(2):216-20
11017081
Blood. 2007 May 1;109(9):3745-8
17197432
J Biol Chem. 2002 Mar 29;277(13):10789-94
11788609
Development. 2006 Sep;133(18):3563-73
16914496
J Biol Chem. 1997 Nov 7;272(45):28512-7
9353312
Gene Expr Patterns. 2008 Feb;8(3):171-80
18068546
J Cell Biol. 2004 Jul 5;166(1):97-109
15240572
J Biol Chem. 2003 Jan 3;278(1):327-34
12399469
Exp Cell Res. 2008 Nov 15;314(19):3593-604
18809396
J Biol Chem. 2005 Feb 25;280(8):7080-7
15591058
Nat Rev Cancer. 2003 Jun;3(6):422-33
12778132